Arkolith/Insider Trading/RCUS/Form 4

Jarrett Jennifer

Chief Operating OfficerArcus Biosciences, Inc. (RCUS) · full profile →Form 4 · filed Nov 12, 2025
Net Selling
Open-Market Buys
$0
Open-Market Sells
$954K
Net Open-Market Flow
-$954K
Transactions
3
2 non-derivative · 1 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Nov 7, 2025Sell(S)50K$18.97$954K214K
Nov 7, 2025Option exercise(M)50K$1.23$62K265K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Nov 7, 2025Option exercise(M)50K$1.23$62K81K

Transaction Codes

S
Open-market sale
M
Option exercise / conversion

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001671311-25-000005) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML